Liquidia founder named director of Kenan Institute
This article was originally published in Scrip
Dr Joseph DeSimone, one of the founders of Liquidia Technologies, a privately-held biotech based in North Carolina, has been named director of the University of North Carolina at Chapel Hill's Franks Hawkins Kenan Institute of Private Enterprise. The Kenan Institute pursues cutting-edge research, educational programmes and public policy initiatives in entrepreneurship, economic development and global competitiveness. Dr DeSimone and colleagues founded Liquidia in 2004 based on discoveries from his lab at UNC using advanced lithographic techniques from the semiconductor industry to create a highly advanced product development and manufacturing platform known as the PRINT platform.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.